Uterine Artery Doppler Indices and Uterocervical Angle Measurment in Prediction of Preterm Labor
NCT ID: NCT07336173
Last Updated: 2026-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
47 participants
OBSERVATIONAL
2026-01-15
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does combination of both uterine artery doppler indices and uterocervical angle measurement increase sensitivity and specificity for prediction of established preterm labor ? Participants already performing uterine artery doppler as part of their regular antenatal care .measurement of anterior uterocervical angle will be added between 24 to 34 weeks gestation to predict preterm labor in candidates .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Intrauterine Growth Restriction
NCT03349671
Umblical Artery Systolic \Diastolic Ratio and Amniotic Fluid Index in Prediction of Fetal Outcome in Term Pregnancy
NCT06347913
Uterocervical Angle and Preterm Labour
NCT04532086
Frequency of Performing Umbilical Artery Doppler in the Third Trimester in High Risk Pregnancy
NCT03584763
Uterine Artery Doppler and 11-14 / 20-22 Weeks of Gestation Pregnancy
NCT04248660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The measurement of UCA in the second trimester of pregnancy is strongly associated with the occurrence of spontaneous Preterm labor and will be measured via transvaginal approach .
Both measurement will be conducted between 24 to 34 weeks gestational .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Trans abdominal ultrasound will be used to measure uterine artery doppler indices Trans vaginal ultrasound will be used to measure anterior uterocervical angle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Pregnant women between 18 and 40 years old of age
3. Singleton pregnancy
4. Gestational age will be confirmed by first trimester ultrasound scan (\<14 weeks).
5. Gestational age between 24 and 34 weeks .
6. Threatened preterm labor which is defined as:
Presence of at least one uterine contraction every 10 minutes lasting ≥30 seconds . Cervical dilatation ≤3 cm . Cervical effacement \<80%.
Exclusion Criteria
1. Ruptured membranes
2. Clinical evidence of Chorioamnionitis.
3. Fetal compromise on evaluation.
4. Severe obstetric complications (e.g., severe Preeclampsia, Eclampsia).
5. Diagnosed intrauterine growth restriction (IUGR).
6. Congenital fetal anomalies.
7. Multiple pregnancies.
8. Prior cervical surgery (e.g., cone biopsy, cerclage).
Non-Obstetric:
1. Significant maternal medical disorders (e.g., chronic hypertension, diabetes mellitus, liver dysfunction).
2. Severe non-obstetric complications (e.g., acute abdomen).
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nourhan Moustafa Elsayed Shalaby
Resident physician doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafr elsheikh university hospital
Kafr ash Shaykh, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ahmed M Fathy, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFSIRB200-597
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.